CY1118557T1 - Μεθοδος αποθηκευσης ενος εμβολιου που περιεχει ανοσοενισχυτικο αργιλιου - Google Patents

Μεθοδος αποθηκευσης ενος εμβολιου που περιεχει ανοσοενισχυτικο αργιλιου

Info

Publication number
CY1118557T1
CY1118557T1 CY20161101263T CY161101263T CY1118557T1 CY 1118557 T1 CY1118557 T1 CY 1118557T1 CY 20161101263 T CY20161101263 T CY 20161101263T CY 161101263 T CY161101263 T CY 161101263T CY 1118557 T1 CY1118557 T1 CY 1118557T1
Authority
CY
Cyprus
Prior art keywords
antigen
composition
loading
storage
container
Prior art date
Application number
CY20161101263T
Other languages
English (en)
Inventor
Isabelle Chacornac
Nabila Ikhelef-Gribi
Frédéric Ronzon
Julien Tirefort
Graf Sandrine Lentsch
Original Assignee
Sanofi Pasteur
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=44059027&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CY1118557(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sanofi Pasteur filed Critical Sanofi Pasteur
Publication of CY1118557T1 publication Critical patent/CY1118557T1/el

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D51/00—Closures not otherwise provided for
    • B65D51/005—Closures provided with linings or internal coatings so as to avoid contact of the closure with the contents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/05—Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
    • A61J1/06—Ampoules or carpules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/05—Actinobacteria, e.g. Actinomyces, Streptomyces, Nocardia, Bifidobacterium, Gardnerella, Corynebacterium; Propionibacterium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/08—Clostridium, e.g. Clostridium tetani
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/099—Bordetella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/29—Hepatitis virus
    • A61K39/292—Serum hepatitis virus, hepatitis B virus, e.g. Australia antigen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65B—MACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
    • B65B3/00—Packaging plastic material, semiliquids, liquids or mixed solids and liquids, in individual containers or receptacles, e.g. bags, sacks, boxes, cartons, cans, or jars
    • B65B3/003—Filling medical containers such as ampoules, vials, syringes or the like
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65B—MACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
    • B65B7/00—Closing containers or receptacles after filling
    • B65B7/16—Closing semi-rigid or rigid containers or receptacles not deformed by, or not taking-up shape of, contents, e.g. boxes or cartons
    • B65B7/28—Closing semi-rigid or rigid containers or receptacles not deformed by, or not taking-up shape of, contents, e.g. boxes or cartons by applying separate preformed closures, e.g. lids, covers
    • B65B7/2821—Closing semi-rigid or rigid containers or receptacles not deformed by, or not taking-up shape of, contents, e.g. boxes or cartons by applying separate preformed closures, e.g. lids, covers applying plugs or threadless stoppers
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D25/00—Details of other kinds or types of rigid or semi-rigid containers
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D39/00—Closures arranged within necks or pouring openings or in discharge apertures, e.g. stoppers
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D51/00—Closures not otherwise provided for
    • B65D51/002—Closures to be pierced by an extracting-device for the contents and fixed on the container by separate retaining means
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D2539/00—Details relating to closures arranged within necks or pouring openings or in discharge apertures, e.g. stoppers
    • B65D2539/001—Details of closures arranged within necks or pouring opening or in discharge apertures, e.g. stoppers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Mechanical Engineering (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Communicable Diseases (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Vascular Medicine (AREA)
  • Anesthesiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)

Abstract

Η εφεύρεση αναφέρεται σε μία μέθοδο για τη φόρτωση και την αποθήκευση μιας σύνθεσης εμβολίου, που περιέχει το αντιγόνο που προσροφάται στο ανοσοενισχυτικό αργιλίου, η οποία (α) περιλαμβάνει (i) τη φόρτωση της σύνθεσης σε ένα δοχείο• και (ii) το κλείσιμο του δοχείου με μια συσκευή, που συγκεκριμένα ενεργεί ως πώμα, η επιφάνεια της συσκευής που βρίσκεται σε επαφή με την σύνθεση είναι επικαλυμμένη με ένα φθοροπολυμερές όπως Teflon™• και/ή (β) φόρτωση της σύνθεσης σε έναν περιέκτη, η εσωτερική επιφάνεια του οποίου είναι επικαλυμμένη με πολυμερισμένη σιλικόνη. Η χρήση του φθοροπολυμερούς ή της πολυμερισμένης σιλικόνης βελτιστοποιεί τη σταθερότητα του προσροφημένου αντιγόνου κατά την αποθήκευση. Σε μια συγκεκριμένη εφαρμογή, το αντιγόνο είναι το επιφανειακό αντιγόνο της ηπατίτιδας Β και το ανοσοενισχυτικό αργιλίου είναι οξυ-υδροξείδιο.
CY20161101263T 2010-10-18 2016-12-07 Μεθοδος αποθηκευσης ενος εμβολιου που περιεχει ανοσοενισχυτικο αργιλιου CY1118557T1 (el)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR1058464A FR2966044B1 (fr) 2010-10-18 2010-10-18 Procede de conditionnement d'un vaccin contenant un adjuvant d'aluminium
US201161454248P 2011-03-18 2011-03-18
PCT/EP2011/068090 WO2012052394A1 (en) 2010-10-18 2011-10-17 Method of storing a vaccine containing an aluminum adjuvant

Publications (1)

Publication Number Publication Date
CY1118557T1 true CY1118557T1 (el) 2017-07-12

Family

ID=44059027

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20161101263T CY1118557T1 (el) 2010-10-18 2016-12-07 Μεθοδος αποθηκευσης ενος εμβολιου που περιεχει ανοσοενισχυτικο αργιλιου

Country Status (33)

Country Link
US (2) US9066895B2 (el)
EP (1) EP2629792B1 (el)
JP (2) JP5890837B2 (el)
KR (1) KR101875828B1 (el)
CN (2) CN103140239A (el)
AP (1) AP2013006876A0 (el)
AR (2) AR084491A1 (el)
AU (1) AU2011317649B2 (el)
BR (1) BR112013009524B1 (el)
CA (1) CA2811075C (el)
CR (1) CR20130223A (el)
CY (1) CY1118557T1 (el)
DK (1) DK2629792T3 (el)
EA (1) EA026876B1 (el)
ES (1) ES2606545T3 (el)
FR (1) FR2966044B1 (el)
GE (1) GEP20156238B (el)
GT (1) GT201300094A (el)
HR (1) HRP20161637T1 (el)
HU (1) HUE031210T2 (el)
IL (1) IL225431A (el)
LT (1) LT2629792T (el)
ME (1) ME02614B (el)
MX (1) MX342345B (el)
NZ (1) NZ609973A (el)
PE (1) PE20140850A1 (el)
PL (1) PL2629792T3 (el)
PT (1) PT2629792T (el)
RS (1) RS55520B1 (el)
SI (1) SI2629792T1 (el)
UA (1) UA113049C2 (el)
WO (1) WO2012052394A1 (el)
ZA (1) ZA201303164B (el)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8627816B2 (en) 2011-02-28 2014-01-14 Intelliject, Inc. Medicament delivery device for administration of opioid antagonists including formulations for naloxone
US8939943B2 (en) 2011-01-26 2015-01-27 Kaleo, Inc. Medicament delivery device for administration of opioid antagonists including formulations for naloxone
EP3858405B1 (en) 2012-06-01 2023-04-05 Novartis AG Syringe
EP2861526A4 (en) * 2012-06-18 2015-12-16 Innova Dynamics Inc AGGLOMERATE REDUCTION IN A NANODRAHUSUSPENSION STORED IN A CONTAINER
JOP20200175A1 (ar) 2012-07-03 2017-06-16 Novartis Ag حقنة
CN103471902A (zh) * 2013-09-22 2013-12-25 北京智飞绿竹生物制药有限公司 一种解吸附方法及其应用
US9517307B2 (en) 2014-07-18 2016-12-13 Kaleo, Inc. Devices and methods for delivering opioid antagonists including formulations for naloxone
US10406290B2 (en) * 2015-02-03 2019-09-10 Merz Pharma Gmbh & Co. Kgaa Botulinum toxin prefilled plastic syringe
CA3007276C (en) 2015-12-03 2021-12-28 Regeneron Pharmaceuticals, Inc. Use of vegf inhibitor to treat macular degeneration in a patient population
CA3047329A1 (en) 2016-12-28 2018-07-05 Sanbio, Inc. Cell delivery system and methods of operation thereof
EP3769082A4 (en) * 2018-03-20 2021-12-15 Sanofi Pasteur Limited METHODS FOR DETERMINING THE CONCENTRATION OF ADJUVANT PROTEIN AND THE PERCENTAGE OF ADSORPTION USING INTRINSIC FLUORESCENCE
US11519020B2 (en) 2018-05-25 2022-12-06 Regeneron Pharmaceuticals, Inc. Methods of associating genetic variants with a clinical outcome in patients suffering from age-related macular degeneration treated with anti-VEGF
DE102018124115A1 (de) * 2018-09-28 2020-04-02 Schott Schweiz Ag Primärpackmittel für pharmazeutische Substanzen
CA3157652A1 (en) * 2019-10-16 2021-04-22 Janssen Vaccines & Prevention B.V. Vaccine product
CN113274492B (zh) * 2021-05-21 2022-06-17 大连理工大学 一种基于羟基氧化铝纳米羧基改性的复合疫苗佐剂的制备方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2545540B2 (ja) * 1987-05-29 1996-10-23 株式会社 大協精工 両面ラミネ−トゴム栓
PT835663E (pt) * 1992-05-23 2010-01-04 Glaxosmithkline Biolog Sa Vacinas combinadas compreendendo o antigénio de superfície da hepatite b e outros antigénios
EP1175912A1 (en) * 1993-03-23 2002-01-30 SmithKline Beecham Biologics SA Vaccine compositions containing 3-O deacylated monophosphoryl lipid A
US6200627B1 (en) * 1998-03-17 2001-03-13 Becton, Dickinson And Company Low silicone glass prefillable syringe
AT408615B (de) * 1998-09-15 2002-01-25 Immuno Ag Neue influenzavirus-impfstoffzusammensetzung
KR100385711B1 (ko) * 2000-07-05 2003-05-27 녹십자백신 주식회사 디프테리아, 파상풍 톡소이드와 백일해균 및ｂ형간염표면항원을 포함한 4가 혼합백신 및 그 제조방법
GB0118249D0 (en) * 2001-07-26 2001-09-19 Chiron Spa Histidine vaccines
KR101092043B1 (ko) * 2002-04-22 2011-12-12 바이오니취 라이프 사이언시즈 인코포레이티드 올리고뉴클레오티드 조성물 및 면역 반응 조절시 이의 용도
JP2004298220A (ja) * 2003-03-28 2004-10-28 Terumo Corp プレフィルドシリンジ
AR044302A1 (es) * 2003-05-13 2005-09-07 Ares Trading Sa Formulaciones con proteinas liquidas estabilizadas en recipientes farmaceuticos
GB0610140D0 (en) * 2006-05-22 2006-06-28 Insense Ltd Protein stability
GB0522765D0 (en) * 2005-11-08 2005-12-14 Chiron Srl Combination vaccine manufacture
TW200806315A (en) * 2006-04-26 2008-02-01 Wyeth Corp Novel formulations which stabilize and inhibit precipitation of immunogenic compositions
GB0609612D0 (en) 2006-05-15 2006-06-21 Glaxosmithkline Biolog Sa Detection method and kit
WO2008076819A2 (en) * 2006-12-18 2008-06-26 Altus Pharmaceuticals Inc. Human growth hormone formulations
BRPI0909820A2 (pt) * 2008-03-05 2015-08-11 Sanofi Pasteur Processo para estabilização de composição de vacina contra gripe, para estabilização de composição de vacina contendo adjuvante e para preparação de vacina, composições de vacina, kit de vacina e método de estocagem de uma matéria prima
WO2010064667A1 (ja) * 2008-12-03 2010-06-10 電気化学工業株式会社 シリンジ

Also Published As

Publication number Publication date
EA201390585A1 (ru) 2014-03-31
EA026876B1 (ru) 2017-05-31
AR120025A2 (es) 2022-01-26
ES2606545T3 (es) 2017-03-24
JP5890837B2 (ja) 2016-03-22
ZA201303164B (en) 2014-06-25
US20120091026A1 (en) 2012-04-19
IL225431A0 (en) 2013-06-27
EP2629792B1 (en) 2016-11-23
FR2966044B1 (fr) 2012-11-02
KR101875828B1 (ko) 2018-07-06
JP2016093534A (ja) 2016-05-26
CA2811075A1 (en) 2012-04-26
CN107753944A (zh) 2018-03-06
JP2013541380A (ja) 2013-11-14
PL2629792T3 (pl) 2017-07-31
ME02614B (me) 2017-06-20
UA113049C2 (xx) 2016-12-12
LT2629792T (lt) 2017-01-10
GT201300094A (es) 2014-11-06
NZ609973A (en) 2014-09-26
AU2011317649B2 (en) 2014-09-18
FR2966044A1 (fr) 2012-04-20
PE20140850A1 (es) 2014-08-01
EP2629792A1 (en) 2013-08-28
SI2629792T1 (sl) 2017-04-26
AR084491A1 (es) 2013-05-22
CR20130223A (es) 2013-06-27
IL225431A (en) 2017-07-31
US9066895B2 (en) 2015-06-30
BR112013009524B1 (pt) 2021-01-26
AU2011317649A1 (en) 2013-03-28
JP6577369B2 (ja) 2019-09-18
DK2629792T3 (da) 2017-01-02
PT2629792T (pt) 2016-12-16
CA2811075C (en) 2020-01-14
BR112013009524A2 (pt) 2018-12-11
WO2012052394A1 (en) 2012-04-26
MX342345B (es) 2016-09-26
HUE031210T2 (en) 2017-07-28
RS55520B1 (sr) 2017-05-31
GEP20156238B (en) 2015-01-26
KR20130126615A (ko) 2013-11-20
CN103140239A (zh) 2013-06-05
US20150259111A1 (en) 2015-09-17
AP2013006876A0 (en) 2013-05-31
US9938055B2 (en) 2018-04-10
MX2013003735A (es) 2013-07-29
HRP20161637T1 (hr) 2017-03-10

Similar Documents

Publication Publication Date Title
CY1118557T1 (el) Μεθοδος αποθηκευσης ενος εμβολιου που περιεχει ανοσοενισχυτικο αργιλιου
CY1126090T1 (el) Μεθοδος και συστημα για την αποτροπη βιολογικης ρυπανσης σε επιφανειες
CY1120335T1 (el) Εγχυτης και μεθοδος συναρμολογησης
CY1121958T1 (el) Συσκευη και μεθοδος για τη μεταφορα υλικου ευαισθητου στη θερμοκρασια
CY1121341T1 (el) Δοκιμες για την ανιχνευση της παρουσιας ή της ποσοτητας αντισωματος κατα αντισωματος φαρμακου
MX2016014871A (es) Dispositivo para recolectar, transportar y almacenar biomoleculas de una muestra biologica.
CY1113049T1 (el) Εμπορευματοκιβωτιο
BR112018009953A8 (pt) embalagem farmacêutica pré-preenchida, formulação líquida de um antagonista de vegf em uma embalagem farmacêutica pré-preenchida, embalagem farmacêutica pré-preenchida para o uso e kit
EA201791148A1 (ru) Способ определения абсолютных количеств hla-рестриктированных раковых пептидов, образовавшихся в результате естественного процессинга
EP2539351A4 (en) LIQUID FOR ADJUSTING CONTACT LENSES
CY1118200T1 (el) Πολυπεπτιδια, πολυνουκλεοτιδια και συνθεσεις για χρηση στη θεραπεια λανθανουσας φυματιωσης
RU2016149370A (ru) Способ хранения вакцины с эмульсионным адъювантом в смазанном медицинском инъекционном устройстве
CL2016001912A1 (es) Vacunas comestibles en base a algas
CL2011000329A1 (es) Aparato para transportar un articulo que incluye un armazon y un soporte acoplado operativamente al armazon, en que el soporte es movible en relacion con el aparato de tal manera, que el aparato proporciona una primera configuracion para retener el articulo y una segunda configuracion para recibir o descargar el articulo.
CY1119912T1 (el) Αντιγονα και συνδυασμοι αντιγονων pseudomonas
EP2559762A4 (en) NEW MONOCLONAL ANTIBODY ANTI-HSP90
CL2017001470A1 (es) Composiciones de polietileno que tienen propiedades de bisagra viva
TW201614050A (en) Polymerizable composition and film using same
CO2018004061A2 (es) Proceso de tratamiento térmico que comprende irradiar un sustrato que comprende una lámina transparente recubierta en una de sus caras con una pila de capas delgadas, bajo una atmósfera que contiene oxígeno (o2) y sustrato asociado
TH134129B (th) วิธีเก็บรักษาวัคซีนที่มีอะลูมินัม แอดจูแวนท์
TWI799534B (zh) 基板收納容器
TH134129A (th) วิธีเก็บรักษาวัคซีนที่มีอะลูมินัม แอดจูแวนท์
TWD191585S (zh) Emulsion tank
EA201690319A1 (ru) Способ in vitro для определения стабильности композиций, содержащих растворимый fc-гамма-рецептор(ы)
JP1726831S (ja) 検体保管用容器